Consolidated Statements of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Beginning balances at Jan. 31, 2012	$ (68,266)	$ 1,899	$ 8,418,685	$ (8,488,850)	$ 0
Shares, Beginning balance at Jan. 31, 2012		1,898,727
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net loss	(84,074)			(40,157)	(43,917)
Ending balances at Jan. 31, 2013	(152,340)	1,899	8,418,685	(8,529,007)	(43,917)
Shares, Beginning balance at Jan. 31, 2013		1,898,727
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net loss	(81,575)			0	(81,575)
Adjustments to outstanding shares per stock transfer amount (shares)		848
Adjustments to outstanding shares per stock transfer amount		1	(1)
Ending balances at Jan. 31, 2014	$ (233,915)	$ 1,900	$ 8,418,684	$ (8,529,007)	$ (125,492)
Shares, Ending balance at Jan. 31, 2014		1,899,575